In patients with GPA/MPA, the observed reporting rate of PML between 2009 (first company-sponsored clinical trials in GPA/MPA) and November 2015 was also very low (< 1 case per 10,000 patients). The gene discussed is PML; the disease is granulomatosis with polyangiitis.